Report

Vifor Pharma AG : CSL offering CHF 167 in cash per Vifor Pharma share

>Speculation about CSL’s interest in Vifor Pharma started 2 weeks ago - On 2 December, the Australian press speculated about CSL being interested in acquiring Vifor Pharma. Shares of Vifor have suffered during the coronavirus pandemic with the company also having suffered setbacks to key R&D programmes. Its share price was trading near to its lows, when the speculation started. We already concluded at that point that this combination would make sense as it would broad...
Underlying
Vifor Pharma AG

Vifor Pharma is a holding company. Through its subsidiaries, Co. develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. Pharma markets pharmaceutical iron-based products and offers a broad range of OTC products, prescription products, herbal remedies and parapharmaceutical products. Logistics delivers supplies to pharmacies, physicians, drugstores and hospitals and also handles and coordinates the purchase, sale, warehousing and distribution of products for third parties. Healthcare Information provides ways of networking the healthcare market. Retail runs pharmacies and participates in Coop Vitality.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch